Transition From Full Mu Opioid Agonists to Buprenorphine in Opioid Dependent Patients—A Critical Review
Methadone, a full opioid agonist at the mu-, kappa-, and delta-receptor, and buprenorphine, a partial agonist at the mu receptor, are first-line medications in opioid maintenance treatment. Transition from methadone to buprenorphine may precipitate withdrawal, and no accepted algorithm for this proc...
Guardado en:
Autor principal: | Michael Soyka |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9a223c56bc1442dfa904366310df96ed |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Association between Participation in Counseling and Retention in a Buprenorphine-Assisted Treatment Program for People Experiencing Homelessness with Opioid Use Disorder
por: Amanda R. W. Berry, et al.
Publicado: (2021) -
Design and implementation of a cohort study of persons living with HIV infection who are initiating medication treatment for opioid use disorder to evaluate HIV-1 persistence
por: Alysse Schultheis, et al.
Publicado: (2021) -
Exploring Influences on Theory of Mind Impairment in Opioid Dependent Patients
por: Katharina Eidenmueller, et al.
Publicado: (2021) -
Biphalin—A Potent Opioid Agonist—As a Panacea for Opioid System-Dependent Pathophysiological Diseases?
por: Patrycja Redkiewicz, et al.
Publicado: (2021) -
Opioid Therapy in Cancer Patients and Survivors at Risk of Addiction, Misuse or Complex Dependency
por: Joseph V. Pergolizzi, et al.
Publicado: (2021)